TABLE 3.
Descriptive Characteristics and CRCCP Variables by Clinic Outcome Status
| Q4s | Q1s | P | |||
|---|---|---|---|---|---|
|
|
|
||||
| No. | %a | No. | %a | ||
| Descriptive characteristic | |||||
| Urbanicity | .094 | ||||
| Metropolitan | 57 | 75.0 | 50 | 64.9 | |
| Urban/nonmetropolitan | 12 | 15.8 | 23 | 29.9 | |
| Rural | 7 | 9.2 | 4 | 5.2 | |
| Clinic type | <.001 | ||||
| FQHC/CHC | 63 | 80.8 | 63 | 80.8 | |
| Health system/hospital | 14 | 17.9 | 1 | 1.3 | |
| All other | 1 | 1.3 | 14 | 17.9 | |
| Health system size | .721 | ||||
| <5 clinics | 16 | 20.8 | 20 | 26.0 | |
| 5 to <25 clinics | 40 | 51.9 | 36 | 46.8 | |
| ≥25 clinics | 21 | 27.3 | 21 | 27.3 | |
| Clinic size | .527 | ||||
| <500 patients | 27 | 34.6 | 23 | 29.5 | |
| 500 to ≤1500 patients | 34 | 43.6 | 32 | 41.0 | |
| >1500 patients | 17 | 21.8 | 23 | 29.5 | |
| % of uninsured patients | .821 | ||||
| <5% | 27 | 34.6 | 22 | 33.9 | |
| 5% to ≤20% | 27 | 34.6 | 20 | 30.8 | |
| >20% | 4 | 30.8 | 23 | 35.4 | |
| CRCCP variable | |||||
| Free fecal test kits | .594 | ||||
| Yes | 16 | 22.5 | 20 | 26.3 | |
| No | 55 | 77.5 | 56 | 73.7 | |
| Primary CRC test type | .021 | ||||
| FOBT/FIT | 44 | 58.7 | 44 | 57.1 | |
| Colonoscopy | 14 | 18.7 | 26 | 33.8 | |
| Varies/unknown | 17 | 22.7 | 7 | 9.1 | |
| CRC screening policy during PY2 | .667 | ||||
| Yes | 62 | 79.5 | 59 | 76.6 | |
| No | 16 | 20.5 | 18 | 23.4 | |
| CRC champion during PY2 | .028 | ||||
| Yes | 73 | 93.6 | 64 | 82.1 | |
| No | 5 | 6.4 | 14 | 17.9 | |
| Provider delivery strategy implemented during PY2 | .229 | ||||
| Yes | 74 | 94.9 | 70 | 89.7 | |
| No | 4 | 5.1 | 8 | 10.3 | |
| EBI focus during PY2 | .055 | ||||
| Patient or provider only | 5 | 6.4 | 8 | 10.3 | |
| Mixed | 72 | 92.3 | 63 | 80.8 | |
| No EBIs | 1 | 1.3 | 7 | 9.0 | |
| No. of EBIs implemented during PY2 | .044 | ||||
| 0 | 1 | 1.3 | 7 | 9.0 | |
| 1 or 2 | 11 | 14.1 | 17 | 21.8 | |
| 3 | 14 | 17.9 | 16 | 20.5 | |
| 4 | 52 | 66.7 | 38 | 48.7 | |
| No. of enhanced EBIs implemented during PY2 | .090 | ||||
| 0 | 10 | 12.8 | 17 | 21.8 | |
| 1 or 2 | 42 | 53.8 | 29 | 37.2 | |
| 3 or 4 | 26 | 33.3 | 32 | 41.0 | |
| No. of new EBIs implemented during PY2 | .006 | ||||
| 0 | 45 | 57.7 | 62 | 79.5 | |
| 1 | 28 | 35.9 | 11 | 14.1 | |
| 2 or 4 | 5 | 6.4 | 5 | 6.4 | |
| Change in No. of EBIs implemented between PY1 and PY2 | <.001 | ||||
| −1 or −2 | 4 | 5.1 | 10 | 12.8 | |
| 0 | 29 | 37.2 | 49 | 62.8 | |
| +1 | 22 | 28.2 | 10 | 12.8 | |
| +2 to +4 | 23 | 29.5 | 9 | 11.5 | |
| Change in No. of enhanced EBIs between PY1 and PY2 | .591 | ||||
| −1 or −2 | 3 | 3.8 | 6 | 7.7 | |
| 0 | 40 | 51.3 | 42 | 53.8 | |
| +1 | 17 | 21.8 | 12 | 15.4 | |
| +2 or +3 | 18 | 23.1 | 18 | 23.1 | |
| Frequency of implementation support during PY2 | .439 | ||||
| Weekly or monthly | 61 | 78.2 | 64 | 83.1 | |
| Quarterly, semiannually, or annually | 17 | 21.8 | 13 | 16.9 | |
Abbreviations: CHC, community health center; CRC, colorectal cancer; CRCCP, Colorectal Cancer Control Program; EBI, evidence-based intervention; FIT, fecal immunochemical test; FOBT, fecal occult blood test; FQHC, federally qualified health center; PY1, program year 1; PY2, program year 2; Q1, lowest quartile; Q4, highest quartile.
a
The column percentages do not necessarily sum to 100.0% because of rounding.